Taiyen Biotech Valuation
| 1737 Stock | TWD 32.30 0.05 0.15% |
At this time, the company appears to be fairly valued. Taiyen Biotech has a current Real Value of NT$33.04 per share. The regular price of the company is NT$32.3. Our model measures the value of Taiyen Biotech from inspecting the company fundamentals such as Return On Equity of 0.0642, shares outstanding of 200 M, and Operating Margin of 0.12 % as well as reviewing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Taiyen Biotech's price fluctuation is very steady at this time. Calculation of the real value of Taiyen Biotech is based on 3 months time horizon. Increasing Taiyen Biotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Taiyen stock is determined by what a typical buyer is willing to pay for full or partial control of Taiyen Biotech Co. Since Taiyen Biotech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Taiyen Stock. However, Taiyen Biotech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 32.3 | Real 33.04 | Hype 32.35 |
The intrinsic value of Taiyen Biotech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Taiyen Biotech's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Taiyen Biotech Co helps investors to forecast how Taiyen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Taiyen Biotech more accurately as focusing exclusively on Taiyen Biotech's fundamentals will not take into account other important factors: Taiyen Biotech Total Value Analysis
Taiyen Biotech Co is presently anticipated to have takeover price of 4.82 B with market capitalization of 6.53 B, debt of 53.08 M, and cash on hands of 2.14 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Taiyen Biotech fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.82 B | 6.53 B | 53.08 M | 2.14 B |
Taiyen Biotech Investor Information
About 48.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.0. In the past many companies with similar price-to-book ratios have beat the market. Taiyen Biotech last dividend was issued on the 23rd of August 2022. The entity had 0:1 split on the 16th of December 2013. Taiyen Biotech Co is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Taiyen Biotech Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Taiyen Biotech has an asset utilization ratio of 48.37 percent. This indicates that the Company is making NT$0.48 for each dollar of assets. An increasing asset utilization means that Taiyen Biotech Co is more efficient with each dollar of assets it utilizes for everyday operations.Taiyen Biotech Ownership Allocation
Taiyen Biotech shows a total of 200 Million outstanding shares. Taiyen Biotech maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Taiyen Biotech Profitability Analysis
The company reported the revenue of 4.1 B. Net Income was 393.23 M with profit before overhead, payroll, taxes, and interest of 1.37 B.About Taiyen Biotech Valuation
Our relative valuation model uses a comparative analysis of Taiyen Biotech. We calculate exposure to Taiyen Biotech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Taiyen Biotech's related companies.Taiyen Biotech Co., Ltd. provides various health and beauty products under the TAIYEN brand Hong Kong, Taiwan, Mainland China, and Macau. The company was founded in 1952 and is based in Tainan, Taiwan. TAIYEN BIOTECH is traded on Taiwan Stock Exchange in Taiwan.
8 Steps to conduct Taiyen Biotech's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Taiyen Biotech's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Taiyen Biotech's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Taiyen Biotech's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Taiyen Biotech's revenue streams: Identify Taiyen Biotech's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Taiyen Biotech's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Taiyen Biotech's growth potential: Evaluate Taiyen Biotech's management, business model, and growth potential.
- Determine Taiyen Biotech's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Taiyen Biotech's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Taiyen Stock Analysis
When running Taiyen Biotech's price analysis, check to measure Taiyen Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taiyen Biotech is operating at the current time. Most of Taiyen Biotech's value examination focuses on studying past and present price action to predict the probability of Taiyen Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taiyen Biotech's price. Additionally, you may evaluate how the addition of Taiyen Biotech to your portfolios can decrease your overall portfolio volatility.